SEC Form D private-offering filing

Tango Therapeutics, Inc.

Name: Tango Therapeutics, Inc. - new SEC Form D private-offering filing, Boston, MA
Published: 2025-10-28

A new SEC Form D private-offering notice from Boston, MA, a $14,999,995 filer-stated offering target in Biotech. The source filing is one click away.

Tango Therapeutics, Inc. site↗ Verified via SEC Form D

Clinical stage biotechnology company developing cancer medicines that exploit synthetic lethality, genetically targeted vulnerabilities in tumors.

Filed 2025-10-28Filed to raise $14,999,995First money in 2025-10-24Raised so far $14,999,995HQ (as filed) Boston, MASector Biotech ✓Stage (inferred) EarlyCall status Needs classification

Source linked the Form D on EDGAR↗Website verified tangotx.com↗Named in the filing 9 executives & directors

Open this row on the live feed →More new filings in Massachusetts →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.